Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Jan;27(1):77-80.
doi: 10.1002/jcla.21565.

Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid?

Affiliations
Comparative Study

Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid?

Amitava Dasgupta et al. J Clin Lab Anal. 2013 Jan.

Abstract

Background: Both immunoassays and chromatographic methods are available for therapeutic drug monitoring of mycophenolic acid (MPA), an immunosuppressant. We studied the suitability of cloned enzyme donor immunoassay (CEDIA) assay for routine monitoring of MPA by comparing values obtained by the CEDIA assay with corresponding values obtained by using a high-performance liquid chromatography combined with ultraviolet detection (HPLC-UV) method.

Methods: We compared MPA concentrations obtained by a reference HPLC-UV method and CEDIA assay on Hitachi 917 analyzer (Roche Diagnostics, Indianapolis, IN) using 60 patient specimens (18 liver transplant recipient and 42 kidney transplant recipients).

Results: When MPA concentrations in all 60 transplant recipients obtained by the HPLC-UV (x-axis) method were compared with corresponding values obtained by the CEDIA method (y-axis), the following regression equation was obtained: y = 1.1558x + 0.2876 (r = 0.97). Interestingly, much lower bias was observed in 42 renal transplant recipients as revealed by the following regression equation; y = 1.1181x + 0.2745 (r = 0.98). However, more significant positive bias was observed in 18 liver transplant recipients as following regression equation as observed: y = 1.3337x + 0.1493 (r = 0.94).

Conclusions: We conclude that MPA concentrations determined by the CEDIA assay showed significant positive bias compared to HPLC-UV method. Therefore, caution must be exercised in interpreting therapeutic drug monitoring result of MPA if CEDIA assay is used.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Linear regression showing comparison of MPA concentrations obtained by HPLC and CEDIA assay in 60 transplant recipients.
Figure 2
Figure 2
Linear regression showing comparison of MPA concentrations obtained by HPLC and CEDIA assay in 42 kidney transplant recipients.
Figure 3
Figure 3
Linear regression showing comparison of MPA concentrations obtained by HPLC and CEDIA assay in 18 liver transplant recipients.

Similar articles

References

    1. Wu JC. Mycophenolate mofetil: Molecular mechanisms of action. Perspex Drug Discov Design 1994;2:185–204.
    1. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 1998;34:429–455. - PubMed
    1. Korecka M, Nikolic D, van Breemen RB, Shaw LM. Inhibition of inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is attributable to the presence of trace quantities of mycophenolic acid. Clin Chem 1999;45:1047–1050. - PubMed
    1. Kaplan B, Meier‐Kriesche HU, Friedman G, et al. The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol 1999;39:715–720. - PubMed
    1. Tredger JM, Brown NW, Adams J, et al. Monitoring mycophenolate in liver transplant recipients: Toward a therapeutic range. Liver Transpl 2004;10:492–502. - PubMed

Publication types

Substances

LinkOut - more resources